Company Profile
ZAI LAB
Description
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company's oncology pipeline includes bemarituzumab, tumor treating fields, tisotumab vedotin, and repotrectinib; and immunology, neuroscience, and infectious disease pipeline comprises efgartigimod and xanomeline and trospium chloride. Zai Lab Limited has license and collaboration agreements with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure Ltd. to develop and commercialize Tumor Treating Fields; Deciphera Pharmaceuticals, LLC to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx BV to develop and commercialize efgartigimod; Bristol-Myers Squibb Company to develop and commercialize tisotumab vedotin and repotrectinib; Amgen Inc. to develop and commercialize bemarituzumab; Innoviva, Inc. to develop and commercialize Sulbactam-Durlobactam; and Karuna Therapeutics, Inc. to develop and commercialize Xanomeline and trospium chloride, as well as strategic collaboration with Pfizer Inc. for sulbactam and durlobactam. The company was incorporated in 2013 and is based in Shanghai, China.
Reports
This company has 3 ESG reports available.
ESG Performance Overview
Select a KPI indicator to view performance trend
KPI Indicators
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
34 Data PointsIndicator | Data Points | Actions |
---|---|---|
Scope 3 GHG Emissions (Business Travel) | 2 | |
Scope 3 GHG Emissions (Fuel and Energy-related Activities (Not Included in Scope 1 or Scope 2)) | 2 | |
Scope 3 GHG Emissions (Upstream Transportation and Distribution) | 2 | |
Scope 3 GHG Emissions (End-of-life Treatment of Sold Products) | 1 | |
Total GHG Emissions Intensity (By Revenue) | 3 | |
Scope 3 GHG Emissions (Waste Generated in Operations) | 1 | |
Total GHG Emissions | 6 | |
Direct GHG Emissions (Scope 1) | 4 | |
Indirect Energy Emissions (Scope 2) | 4 | |
Total Other Indirect Energy Emissions (Scope 3) | 4 | |
Scope 3 GHG Emissions (Purchased Goods/Services) | 2 | |
Scope 3 GHG Emissions (Employee Commuting) | 1 | |
Scope 3 GHG Emissions (Capital Goods) | 2 |
A1.3 Hazardous Waste
14 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total Hazardous Waste Intensity (By Unit Product) | 4 | |
Total Hazardous Waste | 10 |
A1.3: Hazardous Waste
2 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total Hazardous Waste Intensity (By Product Volume) | 2 |
A1.4 Non-Hazardous Waste
6 Data PointsIndicator | Data Points | Actions |
---|---|---|
Non-Hazardous Waste Disposed | 2 | |
Total Non-Hazardous Waste Intensity (By Unit Product) | 4 |
A1.5 Emission Targets
1 Data PointsIndicator | Data Points | Actions |
---|---|---|
Scope 1 and 2 Emissions Reduction Percentage Compared to Last Year | 1 |
A2.1 Energy Consumption
19 Data PointsIndicator | Data Points | Actions |
---|---|---|
Energy Consumption Intensity (By Employee) | 3 | |
Total Energy Consumption | 1 | |
Total Direct Energy Consumption | 1 | |
Gasoline Consumption | 3 | |
Diesel Fuel Consumption | 3 | |
Natural Gas Consumption | 3 | |
Total Indirect Energy Consumption | 1 | |
Purchased Electricity | 3 | |
Grid Electricity Consumption | 1 |
A2.2 Water Consumption
9 Data PointsIndicator | Data Points | Actions |
---|---|---|
Water Consumption | 3 | |
Water Consumption in Office | 1 | |
Water Consumption in Production and Operation | 1 | |
Water Consumption Intensity (By Revenue) | 4 |
A2.5 Total Packaging Material Used
2 Data PointsIndicator | Data Points | Actions |
---|---|---|
Packaging Materials Consumed | 1 | |
Packaging Material Intensity (By Unit Product) | 1 |
B1.1 Amount and Distribution of Workforce
30 Data PointsIndicator | Data Points | Actions |
---|---|---|
Number of Total Employees | 3 | |
Number of Male Employees | 3 | |
Number of Female Employees | 3 | |
Percentage of Male Employees | 3 | |
Percentage of Female Employees | 3 | |
Percentage of Full-time Employees | 2 | |
Percentage of Contractors | 2 | |
Percentage of Employees Aged Below 30 | 3 | |
Percentage of Employees Aged 30-50 | 3 | |
Percentage of Employees Aged Above 50 | 3 | |
Percentage of Employees in Hong Kong and Mainland China | 1 | |
Percentage of Employees in Overseas | 1 |
B2.1 Number and Rate of Work-related Fatalities
21 Data PointsIndicator | Data Points | Actions |
---|---|---|
Number of Work-related Fatalities | 9 | |
Work-related Fatalities Rate | 3 | |
Number of Fatalities as a Result of Work-related Injuries | 4 | |
Number of Fatalities as a Result of Work-related Ill Health | 4 | |
Number of Fatalities of the Last 3 Years | 1 |
B2.2 Lost Days Due to Work Injury
5 Data PointsIndicator | Data Points | Actions |
---|---|---|
Lost Time Injury Frequency Rate (LTIFR/LTIR) | 2 | |
Lost Days Due to Work-related Injuries | 3 |
B3.1 The Percentage of Employees Trained
7 Data PointsIndicator | Data Points | Actions |
---|---|---|
Percentage of Employees Trained | 1 | |
Percentage of Trained Male Employees | 3 | |
Percentage of Trained Female Employees | 3 |
B3.2 Average Training Hours Completed per Employee
5 Data PointsIndicator | Data Points | Actions |
---|---|---|
Average Training Hours per Employee | 1 | |
Average Training Hours (Male) | 2 | |
Average Training Hours (Female) | 2 |
B5.1 Number of Suppliers by Geographical Region
10 Data PointsIndicator | Data Points | Actions |
---|---|---|
Number of Total Suppliers | 3 | |
Number of Suppliers in Asia (Excluding China) | 1 | |
Number of Suppliers in Europe | 3 | |
Number of Suppliers in United Kingdom | 3 |
B5.2 Supplier Engagement and Monitoring
1 Data PointsIndicator | Data Points | Actions |
---|---|---|
Number of Suppliers Signing Social Responsibility Code | 1 |
B6.1 Products Recalled
4 Data PointsIndicator | Data Points | Actions |
---|---|---|
Percentage of Recalled Products for Safety and Health Reasons | 3 | |
Number of Recalled Products for Safety and Health Reasons | 1 |
B6.2 Products Complaints
5 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total Number of Customer Complaints | 2 | |
Number of Products and Service Related Complaints | 2 | |
Number of Complaints Dealt with | 1 |
General
1 Data PointsIndicator | Data Points | Actions |
---|---|---|
Total Electricity Consumption | 1 |
ESG Reports
Year | Report Title | Publication Date | Raw KPIs | Standard KPIs | Processed | Actions |
---|---|---|---|---|---|---|
2024 | 2024 ESG REPORT | 2025-04-29 | 119 | 63 | Yes | |
2023 | 2023 ESG REPORT | 2024-04-30 | 114 | 62 | Yes | |
2022 | 2022 Environmental, Social, and Governance Report | 2023-04-27 | 67 | 51 | Yes |